Eribulin is a chemotherapy drug that is a treatment for advanced breast cancer, usually in people who have already had at least two other courses of chemotherapy and Liposarcoma that can’t be removed with surgery in people who have had chemotherapy.
Researchers are also looking at eribulin in trials for other types of cancer. Eribulin is also called Halaven and its full name is eribulin mesylate. It was originally developed from a sea sponge called Halichondria okadai but is now made in the laboratory.
Cancer Research and Antivirals
Send us your enquiry for Eribulin Mesylate. We offer custom pack sizes at special prices. We aim to respond to your enquiry within 24 hours.
We value your input so if you have suggestions regarding new applications for Eribulin Mesylate email us and we will include your contribution on the website.